Last reviewed · How we verify

NCT06570759: DIFOCCULT-3

Time for a Diagnostic Paradigm Shift From STEMI/NSTEMI to OMI/NOMI

Active, enrolled NA Last updated 3 September 2025
What this trial tests

NA trial testing Early intervention for OMI in Myocardial Infarction in 6,000 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
1 October 2024
Primary endpoint
1 September 2025
1 September 2026

Quick facts

Lead sponsorBaşakşehir Çam & Sakura City Hospital
PhaseNA
StatusActive, enrolled
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposediagnostic
Enrollment6,000
Start date1 October 2024
Primary completion1 September 2025
Estimated completion1 September 2026
Sites18 locations across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Başakşehir Çam & Sakura City Hospital

Who can join

Adults 18 to 99, any sex, with Myocardial Infarction or Myocardial Ischemia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The investigators hypothesize that occlusion myocardial infarction(MI)/non-occlusion MI approach to MI treatment will better predict acute coronary occlusion on coronary angiography, better limit infarct size, better preserve left ventricular function and result in lower long-term adverse cardiac events (all cause mortality, all cause rehospitalization) compared to standard ST-elevation/non-ST-elevation MI paradigm.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. A Diagnostic Paradigm Shift in Acute Myocardial Infarction: Rationale and Design of the DIFOCCULT-3 Trial.
    Aslanger EK, Aggül B, Yıldırımtürk Ö, Karabay CY, et al · · 2025 · cited 5× · PMID 41128712 · DOI 10.1016/j.jacadv.2025.102227
  2. Bifascicular Block Associated With Myocardial Infarction: A Marker of Proximal Left Anterior Descending Artery Occlusion Confirmed by the Artificial Intelligence-Based Smartphone App Queen of Hearts.
    Granata LG, Russo F, Giubilato S, Scarabelli M, et al · · 2025 · cited 1× · PMID 41458651 · DOI 10.7759/cureus.97853

Verify or expand the search:

Other recruiting trials for Myocardial Infarction

Currently open trials in the same condition.

Other Başakşehir Çam & Sakura City Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06570759.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing